Carmen Mora Fernández-rekin lankidetzan egindako argitalpenak (8)

2024

  1. FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 10

2022

  1. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease

    Scientific Reports, Vol. 12, Núm. 1

2020

  1. Association between serum levels of Klotho and inflammatory cytokines in cardiovascular disease: a case-control study

    Aging, Vol. 12, Núm. 2, pp. 1952-1964

  2. Inflammatory targets in diabetic nephropathy

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. Fibroblast growth factor 23 expression in human calcified vascular tissues

    Aging, Vol. 11, Núm. 18, pp. 7899-7913

  2. Pentoxifylline for renal protection in diabetic kidney disease. A model of old drugs for new horizons

    Journal of Clinical Medicine, Vol. 8, Núm. 3

2017

  1. Anti-inflammatory profile of paricalcitol in kidney transplant recipients

    Nefrologia, Vol. 37, Núm. 6, pp. 622-629

  2. Soluble levels and endogenous vascular gene expression of KLOTHO are related to inflammation in human atherosclerotic disease

    Clinical Science, Vol. 131, Núm. 21, pp. 2601-2609